BH3 mimetic-1

Product Name Product Description Specification
SL#002 Bcl-xL Apoptosis
Release: 04/12/2016

Apoptosis is now considered an attractive mechanism underlying a new strategy in the treatment of cancer. Compounds interacting with the Bcl-2 family of proteins are critical regulators of the apoptotic process; therefore, they can be used as anticancer agents.

In library: BH3 mimetic-1
SL#030 a-Helix mimetics
Release: 07/28/2016

α-Helix is the most common type of secondary structure in proteins [1]. It is well known that α-helix mimetics are biologically active in a number of therapeutically significant protein-protein interactions (PPIs). Notable examples include HDM2(HDM4)/p53 and the BCL-2 family of proteins.

In library: BH3 mimetic-1